// App-Quantinova.ai

5016 : Fine tuning metabolism of biochemically active abiraterone metabolites to optimize anti-androgen therapy in prostate cancer.

Researchers

Presenter

  • Nima Sharifi

Principal Investigators

  • Zhenfei Li

  • Mohammad Alyamani

  • Jianneng Li

  • Sunil Upadhyay

  • Steven P. Balk

  • Mary-Ellen Taplin

  • Richard J. Auchus

Medical Centers

  • Cleveland Clinic, Cleveland, OH

  • University of Michigan, Ann Arbor, MI

  • Beth Israel Deaconess Medical Center, Boston, MA

  • Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Urology

Disease

  • Prostate cancer

Biomarkers

  • N/A

Drug/Treatment

  • CB-7598

  • Dutasteride

  • Prednisone

  • Androgen Tear

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved